Intravenous Lidocaine Response as a Predictor for Oral Oxcarbazepine Efficacy in Neuropathic Pain Syndrome: A Prospective Cohort Study.

BACKGROUND Providing pain relief for patients with neuropathic pain syndrome (NPS) is difficult, as sodium-channel blockers pose serious adverse events (AEs). Intravenous (i.v.

Long-term pain outcomes after serial lidocaine infusion in participants with recent onset of peripheral neuropathic pain: A pilot double-blind, randomized, placebo-controlled trial.

Background: This study investigated the outcomes up to 12 weeks after serial lidocaine infusion for early-onset peripheral neuropathic pain.

Methods: This pilot double-blind, randomized, 2-arm placebo-controlled trial recruited 50 participants with onset of peripheral neuropathic pain within the past 6 months and randomized them to either receive lidocaine (3 mg/kg) in normal saline (50 mL) intravenous infusion over 1 hour (lidocaine group) once a week for 4 weeks or 50 mL of normal saline infusion (placebo group) once a week for 4 weeks. Twenty-nine participants completed the protocol; 15 participants were assigned to the lidocaine group and 14 to the placebo group.

Retrograde Epidural Spinal Cord Stimulation for the Treatment of Intractable Neuropathic Pain Following Spinal Cord and Cauda Equina Injuries: A Case Report and Literature Review.

Spinal cord stimulation (SCS) offers an alternative treatment for refractory pain resulting from various etiologies. Generally, SCS electrodes are inserted in an anterograde fashion, moving from caudal to rostral direction. However, there are instances where anterograde placement is unfeasible due to technical limitations.

Transcranial direct current stimulation for spinal cord injury-associated neuropathic pain.

Several types of pain occur following spinal cord injury (SCI); however, neuropathic pain (NP) is one of the most intractable. Invasive and non-invasive brain stimulation techniques have been studied in clinical trials to treat chronic NP following SCI. The evidence for invasive stimulation including motor cortex and deep brain stimulation via the use of implanted electrodes to reduce SCI-related NP remains limited, due to the small scale of existing studies.

Effective Pain Management for Inpatients at Siriraj Hospital: A Retrospective Study.

Background And Objective: The prevalence of severe cancer and non-cancer pain among in patients has been reported at rates ranging from 15% to 36%. We examined the effectiveness of the pain management provided to inpatients by the Siriraj Pain Clinic.

Material And Method: A retrospective chart review was conducted among inpatients who had consulted the clinic between January 2013 and December 2014.

Psychometric Validity and Reliability of the Thai Version of the Neuropathic Pain Symptom Inventory.

Objective: The aim of this study was to evaluate validity and reliability of the Thai version of the Neuropathic Pain Symptom Inventory (NPSI-T) in Thai patients with neuropathic pain. Although the Thai version of Neuropathic Pain Symptom Inventory (NPSI-T) has been linguistically validated, the tool has to be psychometrically validated before applying to neuropathic pain patients in daily practice.

Material And Method: Forty Thai patients with diagnosis of neuropathic pain were enrolled to the study and were evaluated by visual analog scale (VAS), the Thai version of Neuropathic Pain Diagnostic Questionnaire (DN4-T) and NPSI-T questionnaires.